PharmiWeb.com - Global Pharma News & Resources
17-Jul-2019

Hematology Diagnostics Market Size Poised to Touch USD 9.54 Billion by 2026

The Global Hematology Diagnostics Market Size to touch valuation around USD 9.54 billion by 2026, this market is anticipated to grow with 5.8% CAGR during the forecast time period 2019 to 2026. Growing Rise in prevalence of blood disorders, increase in consolidation among market players and diagnostic laboratories, introduction of fully automated hematology analyzers and rapid technological advancements have increased the growth of the global hematology diagnostics market. The market in the North America is likely to expand at significant CAGR due to ease of usage, numerous technological advancements in instruments, and favourable reimbursement scenario.

Consumables segment is expected to register the highest growth rate during the forecast period

The global hematology diagnostics market is divided on the basis of product, test type, and end-user. By product type the hematology diagnostics market, categorized into instruments and consumables. Consumables segment contributed highest market share in 2017 and anticipated to maintain its dominance throughout the forecast period due to increased demand for consumables as incidences of blood disorders and other infections are increased. Growing use of microfluidics technology and introduction of digital imaging systems in hematology laboratories are expected to create opportunities for growth of the global hematology diagnostics market. Factors such as escalating adoption of POC testing hematology products in rising economies, introduction of innovatively propelled hematology items combined with the expanding inclination towards automation are driving the growth of the market. Moreover, the rising availability of wide range of consumables is boosting the growth of the consumable segment. Additionally, instruments category includes fully-automated hematology analyzers and semi-automated hematology analyzers. Growing automation and technological advancements are some of the fundamental factors that are fueling the growth of instruments segment.

Download Free Report Sample Pages at https://www.acumenresearchandconsulting.com/request-sample/935

Increasing incidences of blood disorder diseases is expected to propel the growth of blood count test type segment

Based on test type, the global hematology diagnostics market is bifurcated as blood count, platelet function, hemoglobin and hematocrit. Among these test types, blood count segment is projected to witness fast growth throughout the forecast period owing to the growing cases of blood disorder diseases, rising demand for improved healthcare facilities, increasing aging population and various clinical advancements, rise in demand for preventive diagnosis and treatment monitoring and growing automation are escalating the demand for blood count tests, thereby increasing the growth of the segment.

Constantly increasing geriatric population and sophisticated technological facilities in North America to create more opportunities in the global market

Geographically, the global hematology diagnostics market has been divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2017, North America was estimated the biggest revenue generating region of the market. This growth is attributed to the rising frequency of patients experiencing blood issue, developing predominance of target sicknesses, rising interest for blood transfusions expanding the interest for hematology testing in the region. North America is anticipated to grow at significant CAGR over the forecast period. Asia Pacific is also expected to grow at significant rate during the forecast period owing to the large population and growing awareness towards health issues among people. Factors such as increasing awareness towards health problems, rising disposable income and increased utilization of diagnostic and therapy products. Due to growing automation in the healthcare equipment and increasing expenditure, Europe hematology diagnostics market is anticipated to be on rise in coming years. Regions such as Middle East and Africa and Latin America are also expected to contribute significant revenue share in 2026.

Key Players

The company profiling of key players in the global hematology diagnostics market includes company overview, major business strategies and revenues. The key players of the market are Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Drew Scientific, Bio-Rad Laboratories, EKF Diagnostics, and Beckman Coulter, Inc. Industry participant battle on the basis of price, new innovated product launch, and expanding market presence.

VIEW DETAIL REPORT: https://www.acumenresearchandconsulting.com/hematology-diagnostics-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW 1.1. Definition and Scope 1.1.1. Definition of Hematology Diagnostics 1.1.2. Market Segmentation 1.1.3. List of Abbreviations 1.2. Summary 1.2.1. Market Snapshot 1.2.2. Hematology Diagnostics Market By Product 1.2.2.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison By Product (2015-2026) 1.2.2.2. Global Hematology Diagnostics Market Revenue Share By Product in 2017 1.2.2.3. Instrument 1.2.2.4. Consumables 1.2.2.5. Reagents 1.2.2.6. Stains 1.2.2.7. Others 1.2.3. Hematology Diagnostics Market By Test Type 1.2.3.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison By Test Type (2015-2026) 1.2.3.2. Blood count 1.2.3.3. Platelet function 1.2.3.4. Hemoglobin 1.2.3.5. Hematocrit 1.2.3.6. Others 1.2.4. Hematology Diagnostics Market By End Users 1.2.4.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison By End Users (2015-2026) 1.2.4.2. Hospitals 1.2.4.3. Diagnostic Labs 1.2.4.4. Others 1.2.5. Hematology Diagnostics Market by Geography 1.2.5.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026) 1.2.5.2. North America Hematology Diagnostics Market Revenue and Growth Rate (2015-2026) 1.2.5.3. Europe Hematology Diagnostics Market Revenue and Growth Rate (2015-2026) 1.2.5.4. Asia-Pacific Hematology Diagnostics Market Revenue and Growth Rate (2015-2026) 1.2.5.5. Latin America Hematology Diagnostics Market Revenue and Growth Rate (2015-2026) 1.2.5.6. Middle East and Africa (MEA) Hematology Diagnostics Market Revenue and Growth Rate (2015-2026) CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS 2.1. Market Drivers 2.2. Restraints and Challenges 2.3. Growth Opportunities 2.4. Porterrsquo;s Five Forces Analysis 2.4.1. Bargaining Power of Suppliers 2.4.2. Bargaining Power of Buyers 2.4.3. Threat of Substitute 2.4.4. Threat of New Entrants 2.4.5. Degree of Competition 2.5. Value Chain Analysis 2.6. Cost Structure Analysis 2.6.1. Raw Material and Suppliers 2.6.2. Manufacturing Process Analysis 2.7. Regulatory Compliance 2.8. Competitive Landscape, 2017 2.8.1. Player Positioning Analysis 2.8.2. Key Strategies Adopted By Leading Players CHAPTER 3. MANUFACTURING PLANTS ANALYSIS 3.1. Capacity and Diagnostic Labs Production Date of Global Hematology Diagnostics Major Manufacturers in 2017 3.2. Manufacturing Plants Distribution of Global Hematology Diagnostics Major Manufacturers in 2017 3.3. Ramp;D Status and Technology Source of Global Hematology Diagnostics Major Manufacturers in 2017 3.4. Raw Materials Sources Analysis of Global Hematology Diagnostics Major Manufacturers in 2017 CHAPTER 4. HEMATOLOGY DIAGNOSTICS MARKET BY PRODUCT 4.1. Global Hematology Diagnostics Revenue By Product 4.2. Instrument 4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 4.3. Consumables 4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 4.4. Reagents 4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 4.5. Stains 4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 4.6. Other 4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) CHAPTER 5. HEMATOLOGY DIAGNOSTICS MARKET BY TEST TYPE 5.1. Global Hematology Diagnostics Revenue By Test Type 5.2. Blood count 5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 5.3. Platelet function 5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 5.4. Hemoglobin 5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 5.5. Hematocrit 5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 5.6. Others 5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) CHAPTER 6. HEMATOLOGY DIAGNOSTICS MARKET BY END USERS 6.1. Global Hematology Diagnostics Revenue By End Users 6.2. Hospitals 6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 6.3. Diagnostic Labs 6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 6.4. Others 6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) CHAPTER 7. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY 7.1. North America Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 7.2. North America Hematology Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 7.3. U.S. 7.3.1. U.S. Hematology Diagnostics Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 7.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 7.4. Canada 7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 7.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 7.5. Mexico 7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 7.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) CHAPTER 8. EUROPE HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY 8.1. Europe Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 8.2. Europe Hematology Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 8.3. UK 8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 8.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 8.4. Germany 8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 8.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 8.5. France 8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 8.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 8.6. Spain 8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 8.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 8.7. Rest of Europe 8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 8.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) CHAPTER 9. ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY 9.1. Asia-Pacific Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 9.2. Asia-Pacific Hematology Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 9.3. China 9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 9.4. Japan 9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 9.5. India 9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 9.6. Australia 9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 9.7. South Korea 9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 9.8. Rest of Asia-Pacific 9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.8.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) CHAPTER 10. LATIN AMERICA HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY 10.1. Latin America Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 10.2. Latin America Hematology Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 10.3. Brazil 10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 10.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 10.4. Argentina 10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 10.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 10.5. Rest of Latin America 10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 10.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) CHAPTER 11. MIDDLE EAST HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY 11.1. Middle East Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 11.2. Middle East Hematology Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 11.3. Saudi Arabia 11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 11.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 11.4. UAE 11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 11.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 11.5. Rest of Middle East 11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 11.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) CHAPTER 12. AFRICA HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY 12.1. Africa Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 12.2. Africa Hematology Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 12.3. South Africa 12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 12.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 12.4. Egypt 12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 12.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) 12.5. Rest of Africa 12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 12.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million) 12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million) CHAPTER 13. COMPANY PROFILE 13.1. Abbott Laboratories 13.1.1. Company Snapshot 13.1.2. Overview 13.1.3. Financial Overview 13.1.4. Type Portfolio 13.1.5. Key Developments 13.1.6. Strategies 13.2. Ortho Clinical Diagnostics 13.2.1. Company Snapshot 13.2.2. Overview 13.2.3. Financial Overview 13.2.4. Type Portfolio 13.2.5. Key Developments 13.2.6. Strategies 13.3. Sysmex Corporation 13.3.1. Company Snapshot 13.3.2. Overview 13.3.3. Financial Overview 13.3.4. Type Portfolio 13.3.5. Key Developments 13.3.6. Strategies 13.4. Boule Diagnostics 13.4.1. Company Snapshot 13.4.2. Overview 13.4.3. Financial Overview 13.4.4. Type Portfolio 13.4.5. Key Developments 13.4.6. Strategies 13.5. F. Hoffmann-La Roche Ltd. 13.5.1. Company Snapshot 13.5.2. Overview 13.5.3. Financial Overview 13.5.4. Type Portfolio 13.5.5. Key Developments 13.5.6. Strategies 13.6. Drew Scientific 13.6.1. Company Snapshot 13.6.2. Overview 13.6.3. Financial Overview 13.6.4. Type Portfolio 13.6.5. Key Developments 13.6.6. Strategies 13.7. Bio-Rad Laboratories 13.7.1. Company Snapshot 13.7.2. Overview 13.7.3. Financial Overview 13.7.4. Type Portfolio 13.7.5. Key Developments 13.7.6. Strategies 13.8. EKF Diagnostics 13.8.1. Company Snapshot 13.8.2. Overview 13.8.3. Financial Overview 13.8.4. Type Portfolio 13.8.5. Key Developments 13.8.6. Strategies 13.9. Beckman Coulter, Inc 13.9.1. Company Snapshot 13.9.2. Overview 13.9.3. Financial Overview 13.9.4. Type Portfolio 13.9.5. Key Developments 13.9.6. Strategies 13.10. Others 13.10.1. Company Snapshot 13.10.2. Overview 13.10.3. Financial Overview 13.10.4. Type Portfolio 13.10.5. Key Developments 13.10.6. Strategies CHAPTER 14. RESEARCH APPROACH 14.1. Research Methodology 14.1.1. Initial Data Search 14.1.2. Secondary Research 14.1.3. Primary Research 14.2. Assumptions and Scope

INQUIRY BEFORE BUYING: https://www.acumenresearchandconsulting.com/inquiry-before-buying/935

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/935

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 17-Jul-2019